Skip to content
healthcare.dev

Lotensin HCT

NDC 30698-453, benazepril hydrochloride and hydrochlorothiazide, tablet, from Validus Pharmaceuticals LLC.

Product NDC
30698-453
Status
Listed
Labeler
Validus Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020033
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/30698-453 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENAZEPRIL HYDROCHLORIDE20 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Decreased Blood Pressure [PE]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
30698-453-0130698045301100 TABLET in 1 BOTTLE (30698-453-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/94c4536f-e28e-48b1-8336-b3939917e99d

Use it

Look up 30698-453 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/30698-453 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 30698-453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.